Author

Stefânia Bovo Minto

Dana-Farber Cancer InstituteORCID 0000-0002-8660-3536Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Kevin M. HaigisiD· 2 shared Ainsleigh Scott· 1 shared Alison W. Tisdale· 1 shared Anna Idelevich· 1 shared Bing ShuiiD· 1 shared Christian William JohnsoniD· 1 shared Deborah K. MorrisoniD· 1 shared Elizabeth M. Terrell· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Kevin M. HaigisORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Enteric neurons modulate colorectal cancer cell cycle through a PCSK1 - Methionine-Enkephalin Axis

Philippa Seika, Srinivas N. Puttapaka, Su Min Hong, Ainsleigh Scott, Jared Slosberg, Stefânia Bovo Minto, Kevin M. Haigis, Subhash Kulkarni

This study identifies a neuronal PCSK1-M-ENK pathway in the ENS that suppresses colorectal cancer growth through OGFr activation.

bioRxiv · May 6, 2026 · PreprintCancer Biology

Cooperativity between Ras pathway mutations in colonic tumorigenesis

Christian William Johnson, Anna Idelevich, Bing Shui, Alison W. Tisdale, Eve O’Donoghue, Joshua Cook, Shannon Hull, Moon Hee Yang, Shikha Sheth, Elizabeth M. Terrell, Stefânia Bovo Minto, Deborah K. Morrison, Scott Kopetz, Rona D. Yaeger, Kevin M. Haigis

This study shows that specific KRAS mutations, like A59E, cooperate with other genetic alterations in CRC and affect response to EGFR inhibitors.

bioRxiv · Sep 5, 2025 · PreprintCancer Biology